SI2718257T1 - Postopek za pripravo kristaliničnega dimetil fumarata z visoko čistostjo - Google Patents

Postopek za pripravo kristaliničnega dimetil fumarata z visoko čistostjo Download PDF

Info

Publication number
SI2718257T1
SI2718257T1 SI201231204T SI201231204T SI2718257T1 SI 2718257 T1 SI2718257 T1 SI 2718257T1 SI 201231204 T SI201231204 T SI 201231204T SI 201231204 T SI201231204 T SI 201231204T SI 2718257 T1 SI2718257 T1 SI 2718257T1
Authority
SI
Slovenia
Prior art keywords
quot
minus
term
particular number
number plus
Prior art date
Application number
SI201231204T
Other languages
English (en)
Inventor
John Guzowski
William KIESMAN
Erwin Irdam
Original Assignee
Biogen Ma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47296498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2718257(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Ma Inc. filed Critical Biogen Ma Inc.
Publication of SI2718257T1 publication Critical patent/SI2718257T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/62—Use of additives, e.g. for stabilisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/593—Dicarboxylic acid esters having only one carbon-to-carbon double bond
    • C07C69/60—Maleic acid esters; Fumaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/604—Polycarboxylic acid esters, the acid moiety containing more than two carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Claims (10)

  1. POSTOPEK ZA PRIPRAVO KRISTALINIČNEGA DIMETIL FUMARATA Z VISOKO ČISTOSTJO Patentni zahtevki
    1. Metoda za pripravo dimetil fumarata, ki zajema: reakcijo: (a) fumarne kisline; in (b) metanola; v prisotnosti žveplove kisline; v razmerju metanola in fumarne kisline od približno 5,7 litra do približno 8,6 litra metanola na kilogram fumarne kisline; v reakcijski zmesi za pridobivanje zmesi produkta, ki vključuje nizko raven dimetil sulfata, pri čemer je raven dimetil sulfata nižja od 4,0 ppm; pri čemer izraz »približno« pomeni določeno številko plus ali minus od 1 do 10 %.
  2. 2. Metoda iz patentnega zahtevka 1, pri čemer je raven dimetil sulfata nižja od 3,0 ppm.
  3. 3. Metoda iz patentnega zahtevka 1, pri čemer je raven dimetil sulfata nižja od 2,0 ppm, pri čemer je raven dimetil sulfata po možnosti nižja od 1,0 ppm.
  4. 4. Metoda iz katerega koli patentnega zahtevka 1-3, pri čemer je razmerje fumarna kislina : žveplova kislina v obsegu od približno 1 : 0,01 molarnega ekvivalenta do približno 1 : 0,50 molarnega ekvivalenta; pri čemer izraz »približno« pomeni določeno številko plus ali minus od 1 do 10 %.
  5. 5. Metoda iz katerega koli patentnega zahtevka 1-4, pri čemer reagiranje traja od približno 3,0 ure do približno 48 ur; pri čemer izraz »približno« pomeni določeno številko plus ali minus od 1 do 10 %.
  6. 6. Metoda iz katerega koli patentnega zahtevka 1-5, pri čemer reagiranje poteka pri temperaturi od približno 60 °C do približno 70 °C; pri čemer izraz »približno« pomeni določeno številko plus ali minus od 1 do 10 %.
  7. 7. Metoda iz katerega koli patentnega zahtevka 1-6, pri čemer je količina vode v vhodnih reakcijskih snoveh od približno 2,0 % do približno 5,0 %, pri čemer izraz »približno« pomeni določeno številko plus ali minus od 1 do 10 %.
  8. 8. Metoda iz katerega koli patentnega zahtevka 1-7, pri čemer je razmerje molarnih ekvivalentov fumarna kislina : žveplova kislina v obsegu od približno 1 : 0,01 molarnega ekvivalenta do približno 1 : 0,50 molarnega ekvivalenta, pri čemer je količina vode v vhodnih reakcijskih snoveh od približno 2,0 % do približno 5,0 % in reagiranje traja od približno 3,0 ure do približno 48 ur pri temperaturi od približno 60 °C do približno 70 °C; pri čemer izraz »približno« pomeni določeno številko plus ali minus od 1 do 10 %.
  9. 9. Metoda iz katerega koli patentnega zahtevka 1-8, ki dodatno zajema: zmanjšanje velikosti delcev dimetil fumarata.
  10. 10. Metoda iz patentnega zahtevka 9, pri čemer je zmanjšanje velikosti delcev dimetil fumarata v obsegu od približno 20 pm do približno 250 pm; pri čemer izraz »približno« pomeni določeno številko plus ali minus od 1 do 10 %.
SI201231204T 2011-06-08 2012-06-08 Postopek za pripravo kristaliničnega dimetil fumarata z visoko čistostjo SI2718257T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161494775P 2011-06-08 2011-06-08
EP12796164.7A EP2718257B1 (en) 2011-06-08 2012-06-08 Process for preparing high purity and crystalline dimethyl fumarate
PCT/US2012/041715 WO2012170923A1 (en) 2011-06-08 2012-06-08 Process for preparing high purity and crystalline dimethyl fumarate

Publications (1)

Publication Number Publication Date
SI2718257T1 true SI2718257T1 (sl) 2018-04-30

Family

ID=47296498

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201231204T SI2718257T1 (sl) 2011-06-08 2012-06-08 Postopek za pripravo kristaliničnega dimetil fumarata z visoko čistostjo

Country Status (30)

Country Link
US (1) US9422226B2 (sl)
EP (1) EP2718257B1 (sl)
JP (3) JP6385273B6 (sl)
KR (2) KR20150080037A (sl)
CN (1) CN103649041A (sl)
AU (1) AU2012267524A1 (sl)
BR (1) BR112013031616A2 (sl)
CA (1) CA2838271A1 (sl)
CL (1) CL2013003483A1 (sl)
CO (1) CO6821956A2 (sl)
CY (1) CY1119920T1 (sl)
DK (1) DK2718257T3 (sl)
EA (1) EA201391638A1 (sl)
EC (1) ECSP14013123A (sl)
ES (1) ES2659771T3 (sl)
HR (1) HRP20180203T1 (sl)
HU (1) HUE036085T2 (sl)
IL (1) IL229656A0 (sl)
LT (1) LT2718257T (sl)
ME (1) ME02960B (sl)
MX (1) MX355421B (sl)
NO (1) NO2820009T3 (sl)
NZ (1) NZ618178A (sl)
PE (1) PE20141639A1 (sl)
PL (1) PL2718257T3 (sl)
PT (1) PT2718257T (sl)
RS (1) RS56972B1 (sl)
SG (1) SG195227A1 (sl)
SI (1) SI2718257T1 (sl)
WO (1) WO2012170923A1 (sl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1663197B1 (en) 2003-09-09 2007-12-05 Fumapharm AG The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
LT2801354T (lt) 2004-10-08 2017-06-26 Forward Pharma A/S Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį
MX2011001341A (es) 2008-08-19 2011-03-29 Xenoport Inc Prodrogas de metil hidrogeno fumarato, sus composiciones farmaceuticas, y metodos de uso.
US9422226B2 (en) 2011-06-08 2016-08-23 Biogen Ma Inc. Process for preparing high purity and crystalline dimethyl fumarate
JP2015526476A (ja) 2012-08-22 2015-09-10 ゼノポート，インコーポレイティド メチル水素フマレートの経口剤形およびそのプロドラッグ
US10945984B2 (en) 2012-08-22 2021-03-16 Arbor Pharmaceuticals, Llc Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
AR094277A1 (es) 2012-12-21 2015-07-22 Biogen Idec Inc Derivados de fumarato sustituidos con deuterio
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
PT2970101T (pt) 2013-03-14 2018-10-04 Alkermes Pharma Ireland Ltd Pró-fármacos de fumaratos e seu uso no tratamento de várias doenças
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
CN104098471A (zh) * 2013-04-03 2014-10-15 南京卡文迪许生物工程技术有限公司 富马酸二甲酯多晶型物及其制备方法和药物组合物
WO2014197860A1 (en) 2013-06-07 2014-12-11 Xenoport, Inc. Method of making monomethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
JP2016534133A (ja) 2013-09-06 2016-11-04 ゼノポート，インコーポレイティド （ｎ，ｎ−ジエチルカルバモイル）メチル メチル（２ｅ）ブト−２−エン−１，４−ジオエートの結晶形態、その合成方法及び使用
IN2013MU03070A (sl) * 2013-09-25 2015-07-17 Glenmark Pharmaceuticals Ltd
EP3097075A4 (en) * 2014-01-24 2017-06-21 Shilpa Medicare Limited Process for preparation of dimethyl-(e)-butenedioate
NZ723269A (en) 2014-02-24 2017-04-28 Alkermes Pharma Ireland Ltd Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
CA2939990C (en) 2014-02-28 2018-07-10 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
EP3119741B1 (en) * 2014-03-17 2019-12-18 Biophore India Pharmaceuticals Pvt. Ltd. An improved process for the synthesis of dimethyl fumarate
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2016001093A1 (en) * 2014-07-03 2016-01-07 Synthon B.V. Process for making microcrystalline dimethyl fumarate
CN104151165B (zh) * 2014-08-11 2016-08-24 广东东阳光药业有限公司 制备富马酸二甲酯的方法
CN104761453A (zh) * 2015-04-22 2015-07-08 河南中帅医药科技股份有限公司 一种富马酸二甲酯晶型及其制备方法
AU2016273068A1 (en) * 2015-06-01 2017-12-21 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
CN107920997A (zh) * 2015-06-17 2018-04-17 比奥根Ma公司 富马酸二甲酯颗粒和其药物组合物
CN106316841A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种富马酸二甲酯的制备方法
WO2017013672A1 (en) * 2015-07-23 2017-01-26 Natco Pharma Ltd Process for the preparation of pharmaceutical grade dimethyl fumarate
US10011663B2 (en) 2016-02-04 2018-07-03 Eastman Chemical Company Vulcanizing composition containing cyclododecasulfur and improved cyclododecasulfur compound
RU2616605C1 (ru) * 2016-04-07 2017-04-18 Олег Ростиславович Михайлов Кристаллическая бета - модификация (Е)-диметилбутендиоата, способ её получения и фармацевтическая композиция на её основе
CN107285320A (zh) * 2017-08-02 2017-10-24 内蒙古新福地科技有限公司 一种氟硅酸钠的结晶方法及装置
JP7153069B2 (ja) * 2017-10-10 2022-10-13 ファイザー・インク ロルラチニブ遊離塩基水和物の結晶形態
US11903918B2 (en) 2020-01-10 2024-02-20 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
KR102271575B1 (ko) * 2020-09-16 2021-07-01 김갑용 염의 이온교환법을 이용한 친환경 고효율 에스터화반응 기반의 에스터화합물 제조방법 및 이의 화합물
JP6865489B1 (ja) * 2020-10-20 2021-04-28 株式会社エス・ディー・エス バイオテック ２，３，５，６−テトラクロロ−１，４−ベンゼンジカルボン酸ジメチルの製造方法

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1848724A (en) 1932-03-08 Alphons
US2764609A (en) * 1953-07-24 1956-09-25 Monsanto Chemicals Isomerization of dialkyl maleates to dialkyl fumarates
US3078302A (en) 1958-09-25 1963-02-19 Monsanto Chemicals Production of dialkyl fumarates
US3993684A (en) 1971-08-20 1976-11-23 Western Litho Plate & Supply Co. Monomeric compounds
US5118835A (en) 1976-09-24 1992-06-02 Exxon Research & Engineering Co. Thio-bis(alkyl lactone acid esters) and thio-bis (Hydrocarbyl diacid esters) are usefull additives for lubricating compositions
US4965375A (en) 1976-09-24 1990-10-23 Exxon Research And Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4417062A (en) 1976-09-24 1983-11-22 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4239636A (en) 1978-10-23 1980-12-16 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4866187A (en) 1976-09-24 1989-09-12 Exxon Research & Engineering Company Thio-bis(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4568756A (en) 1976-09-24 1986-02-04 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
JPS60193946U (ja) 1984-03-01 1985-12-24 内山　茂夫 変色炎を有するろうそく
JPS60193946A (ja) * 1984-03-16 1985-10-02 Nippon Oil & Fats Co Ltd ジイソプロピルフマレ−トの製造法
US5149695A (en) 1985-01-15 1992-09-22 Speiser Peter P Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
CH664150A5 (de) 1985-01-15 1988-02-15 Peter Paul Prof Dr Speiser Fumarsaeureprodrug, verfahren zu seiner herstellung und dieses enthaltende darreichungsformen.
JPS61246147A (ja) * 1985-04-22 1986-11-01 Nippon Shokubai Kagaku Kogyo Co Ltd マレイン酸ジアルキルエステルの精製方法
US4866140A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
US4866139A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified, esterified dispersant additives useful in oleaginous compositions
US4906394A (en) 1986-10-07 1990-03-06 Exxon Chemical Patents Inc. Lactone modified mono-or dicarboxylic acid based adduct dispersant compositions
US4963275A (en) 1986-10-07 1990-10-16 Exxon Chemical Patents Inc. Dispersant additives derived from lactone modified amido-amine adducts
US4954276A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
US4954277A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified, esterified or aminated additives useful in oleaginous compositions and compositions containing same
US5032320A (en) 1986-10-07 1991-07-16 Exxon Chemical Patents Inc. Lactone modified mono- or dicarboxylic acid based adduct dispersant compositions
DE3711155A1 (de) 1987-04-02 1988-10-13 Bayer Ag Verfahren zur herstellung von maleinsaeuredimethylester
US4820432A (en) 1987-07-24 1989-04-11 Exxon Chemical Patents Inc. Lactone-modified, Mannich base dispersant additives useful in oleaginous compositions
US4971711A (en) 1987-07-24 1990-11-20 Exxon Chemical Patents, Inc. Lactone-modified, mannich base dispersant additives useful in oleaginous compositions
US5424332A (en) 1987-10-19 1995-06-13 Speiser; Peter P. Pharmaceutical composition and process for the production thereof
US4959389A (en) 1987-10-19 1990-09-25 Speiser Peter P Pharmaceutical preparation for the treatment of psoriatic arthritis
US4943382A (en) 1988-04-06 1990-07-24 Exxon Chemical Patents Inc. Lactone modified dispersant additives useful in oleaginous compositions
US5153352A (en) 1988-10-25 1992-10-06 Bristol-Myers Squibb Company Process for preparation of intermediates of carbocyclic nucleoside analogs
ES2103536T3 (es) 1993-01-21 1997-09-16 Akzo Nobel Nv Dispersiones polimeras acuosas de secado al aire.
CN1103398A (zh) * 1993-11-30 1995-06-07 张治明 一种由顺酐生产富马酸二甲酯的工艺方法
WO1996016091A1 (en) 1994-11-21 1996-05-30 Asahi Kasei Kogyo Kabushiki Kaisha Curable resin and composition
JP4240536B2 (ja) 1996-06-24 2009-03-18 サイテク・テクノロジー・コーポレーシヨン 重合性尿素／ウレイド官能性モノマー
US6239189B1 (en) 1997-04-01 2001-05-29 Henkel Corporation Radiation-polymerizable composition and printing inks containing same
DE19721099C2 (de) 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
US6204410B1 (en) 1997-07-11 2001-03-20 Showa Denko Kabushiki Kaisha Ether compounds and process for producing the same
US6376702B1 (en) 1997-07-11 2002-04-23 Showa Denko K.K. Ether compound, production thereof and curable compositions
GB9724004D0 (en) 1997-11-13 1998-10-21 Kvaerner Process Tech Ltd Process
DE19814358C2 (de) 1998-03-31 2002-01-17 Fumapharm Ag Muri Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn
DE19839566C2 (de) 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
DE19848260C2 (de) 1998-10-20 2002-01-17 Fumapharm Ag Muri Fumarsäure-Mikrotabletten
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
DE10084257B4 (de) 1999-12-27 2007-03-29 Asahi Kasei Kabushiki Kaisha Polyoxymethylen-Harzzusammensetzung
DE10000577A1 (de) 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
US20020002306A1 (en) * 2000-02-15 2002-01-03 Yasushi Kadowaki Method for producing fumaric acid esters
JP2001281800A (ja) 2000-03-31 2001-10-10 Konica Corp 熱現像写真感光材料
US6586452B1 (en) 2000-07-14 2003-07-01 Merck & Co., Inc. C1 to C4 side chain modified nodulisporic acid analogs
US20020098451A1 (en) 2000-09-07 2002-07-25 Tadashi Arimoto Photothermographic material
DE10101307A1 (de) 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
RS52083B (sr) 2001-01-12 2012-06-30 Fumapharm Ag Amidi fumarne kiseline
JP2003160535A (ja) * 2001-11-28 2003-06-03 Nof Corp 不飽和二塩基酸ジエステルの製造方法
EP2105432A1 (en) 2002-02-28 2009-09-30 Sumitomo Chemical Company, Limited Process for Producing Chromone Compound
DE10217314A1 (de) 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
JP2003315960A (ja) 2002-04-25 2003-11-06 Konica Minolta Holdings Inc 銀塩光熱写真ドライイメージング材料
JP4259815B2 (ja) * 2002-06-06 2009-04-30 ダイセル化学工業株式会社 高純度酢酸ブチルの製造方法
EP1663197B1 (en) 2003-09-09 2007-12-05 Fumapharm AG The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
JP4163653B2 (ja) 2004-02-27 2008-10-08 株式会社日本触媒 光学部品用硬化性組成物
WO2007087815A2 (en) 2004-12-17 2007-08-09 Metanomics Gmbh Process for the control of production of fine chemicals
US7557241B2 (en) 2004-08-30 2009-07-07 Sanyo Chemical Industries, Ltd. Method for producing α,β-unsaturated carboxylic acid ester, α,β-unsaturated carboxylic acid ester, and lubricating oil additive
LT2801354T (lt) 2004-10-08 2017-06-26 Forward Pharma A/S Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį
TWI279403B (en) * 2004-10-20 2007-04-21 Eternal Chemical Co Ltd Cyclobutanetetracarboxylate compound and preparation method thereof
EP1812374A1 (en) 2004-11-10 2007-08-01 Aditech Pharma AB Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
KR100960198B1 (ko) 2005-04-22 2010-05-27 캐논 가부시끼가이샤 자성 토너
DE102005022845A1 (de) 2005-05-18 2006-11-23 Fumapharm Ag Thiobernsteinsäurederivate und deren Verwendung
WO2007006307A2 (en) 2005-07-07 2007-01-18 Aditech Pharma Ab Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
WO2007020734A1 (ja) 2005-08-12 2007-02-22 Lion Corporation ナノ平滑性とエッチング耐性を有するフォトレジストポリマーならびにレジスト組成物
WO2007042035A2 (en) 2005-10-07 2007-04-19 Aditech Pharma Ab Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
JP2009510137A (ja) 2005-10-07 2009-03-12 アディテック・ファルマ・アクチボラゲット フマル酸エステルを含む制御放出医薬組成物
JP2009539386A (ja) 2006-06-16 2009-11-19 ガムリンク エー／エス 疎水性酵素配合物を含むチューインガム
HUE032251T2 (en) 2007-02-08 2017-09-28 Biogen Ma Inc Neuroprotection in demyelinating diseases
HRP20220902T3 (hr) 2007-02-08 2022-10-14 Biogen Ma Inc. Pripravci i njihova upotreba u liječenju multiple skleroze
TWI453284B (zh) 2007-08-10 2014-09-21 Genomatica Inc 合成烯酸及其衍生物之方法
EP2219783B1 (en) 2007-10-26 2017-10-11 Purolite International, Ltd. Controlled catalysis
WO2009075303A1 (ja) 2007-12-12 2009-06-18 Mitsubishi Chemical Corporation 脂肪族ポリエステル樹脂及びその製造方法
US8906420B2 (en) 2009-01-09 2014-12-09 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
EP3466420A1 (en) 2009-04-29 2019-04-10 Biogen MA Inc. Dimethyl fumarate for the treatment of friedreich ataxia
CN102471218B (zh) 2009-08-07 2014-11-05 因温斯特技术公司 用于形成二酯的氢化并酯化
HUE025878T2 (en) 2010-02-12 2016-05-30 Biogen Ma Inc Neuroprotection in demyelinating diseases
CN102757346A (zh) 2011-04-26 2012-10-31 中国科学院兰州化学物理研究所 一种富马酸二甲酯的制备方法
SG195049A1 (en) 2011-05-26 2013-12-30 Biogen Idec Inc Methods of treating multiple sclerosis and preserving and/or increasing myelin content
US9422226B2 (en) 2011-06-08 2016-08-23 Biogen Ma Inc. Process for preparing high purity and crystalline dimethyl fumarate
CN102432464A (zh) 2011-12-14 2012-05-02 费近峰 一种富马酸二甲酯的连续生产工艺
CN104220061A (zh) 2012-02-07 2014-12-17 比奥根艾迪克依蒙菲利亚公司 含有富马酸二甲酯的药物组合物
CN102766050A (zh) 2012-08-10 2012-11-07 太仓市运通化工厂 一种富马酸二甲酯的合成方法
AR094277A1 (es) 2012-12-21 2015-07-22 Biogen Idec Inc Derivados de fumarato sustituidos con deuterio
CN103848739A (zh) 2014-03-20 2014-06-11 徐晓宁 一种高纯度富马酸二甲酯的生产方法

Also Published As

Publication number Publication date
MX355421B (es) 2018-04-18
LT2718257T (lt) 2018-03-12
JP2014522413A (ja) 2014-09-04
PT2718257T (pt) 2018-02-26
BR112013031616A2 (pt) 2016-12-06
CA2838271A1 (en) 2012-12-13
KR20150080037A (ko) 2015-07-08
KR20140035995A (ko) 2014-03-24
US20140200363A1 (en) 2014-07-17
ES2659771T3 (es) 2018-03-19
CO6821956A2 (es) 2013-12-31
EP2718257A4 (en) 2015-08-12
PL2718257T3 (pl) 2018-04-30
US9422226B2 (en) 2016-08-23
JP6385273B2 (ja) 2018-09-05
RS56972B1 (sr) 2018-05-31
CN103649041A (zh) 2014-03-19
HRP20180203T1 (hr) 2018-04-06
DK2718257T3 (en) 2018-02-12
CL2013003483A1 (es) 2014-05-09
JP6385273B6 (ja) 2023-12-15
MX2013014320A (es) 2014-01-31
WO2012170923A1 (en) 2012-12-13
SG195227A1 (en) 2013-12-30
PE20141639A1 (es) 2014-11-08
NZ618178A (en) 2016-03-31
EA201391638A1 (ru) 2014-05-30
JP2016155868A (ja) 2016-09-01
EP2718257A1 (en) 2014-04-16
AU2012267524A1 (en) 2013-12-12
JP2018162266A (ja) 2018-10-18
IL229656A0 (en) 2014-01-30
NO2820009T3 (sl) 2018-06-30
HUE036085T2 (hu) 2018-06-28
EP2718257B1 (en) 2017-11-15
ECSP14013123A (es) 2014-06-30
ME02960B (me) 2018-07-20
CY1119920T1 (el) 2018-06-27

Similar Documents

Publication Publication Date Title
SI2718257T1 (sl) Postopek za pripravo kristaliničnega dimetil fumarata z visoko čistostjo
RU2014138168A (ru) Способ получения уксусной кислоты и диметилового эфира
AR072447A1 (es) Proceso para preparar 2- alcoximetilen-4,4-difluoro-3-oxobutiratos de alquilo
WO2012050761A3 (en) Process for preparing an acryloyloxysilane
RU2014138169A (ru) Катализатор и способ получения уксусной кислоты и диметилового эфира
NZ603653A (en) Processes for the preparation of dipyridamole
NZ605608A (en) Method of synthesis of ferroquine by convergent reductive amination
CN103373980B (zh) 三聚甲醛的合成方法
CN103998416A (zh) 制造乙氧基化胺化合物的改进方法
CN102757312A (zh) 一种高选择性低耗能苯甲醇制备方法
CN105481759A (zh) 一种光稳定剂n,n,-双-（2,2,6,6-四甲基-4-哌啶基）间苯二甲酰胺的合成方法
WO2017159814A1 (ja) アルカノールアミン類の製造方法
CN104030886A (zh) 以2,2-二氟-1-卤代乙烷为原料制备2,2-二氟乙醇的方法
CN107814697A (zh) 一种正丙酸铬的制备方法
WO2012054097A8 (en) Use of an acetic acid wash to prepare low-sulfate 5-sulfoisophthalic acid, mono-lithium salt
CN106316859A (zh) 一种微反应器中合成2,4-二氯-3,5-二硝基三氟甲苯的方法
WO2011083955A3 (en) Method for manufacturing crystalline form (i) of clopidogrel hydrogen sulphate
GB201008185D0 (en) Ferrous sulphate monohydrate
CN102659670A (zh) 一种光稳定剂4-对甲苯磺酰胺基-2,2,6,6-四甲基哌啶的制备方法
CN102757321B (zh) 2,6-二甲氧基萘的生产方法
TH145096A (th) กระบวนการสำหรับการเตรียมไดเมทิลฟูมาเรตที่มีความบริสุทธิ์สูงและเป็นผลึก
CN104478931A (zh) 三-1-(2-甲基氮丙啶)氧化膦的制备方法
CN107814704A (zh) 一种正己酸铬的制备方法
CN103030590A (zh) 一种高品位阻聚剂及其制造工艺
CN107814706A (zh) 一种混癸二酸铬的制备方法